These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 29636376)

  • 1. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What do drug transporters really do?
    Nigam SK
    Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition.
    Sugiura T; Kato Y; Tsuji A
    J Control Release; 2006 Nov; 116(2):238-46. PubMed ID: 16876283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
    Liu X
    Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporters and xenobiotic disposition.
    Kim RB
    Toxicology; 2002 Dec; 181-182():291-7. PubMed ID: 12505328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.
    Momper JD; Tsunoda SM; Ma JD
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S82-98. PubMed ID: 27385182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
    Döring B; Petzinger E
    Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational modifications of transporters.
    Czuba LC; Hillgren KM; Swaan PW
    Pharmacol Ther; 2018 Dec; 192():88-99. PubMed ID: 29966598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nuclear receptors in the regulation of drug transporters in the brain.
    Chan GN; Hoque MT; Bendayan R
    Trends Pharmacol Sci; 2013 Jul; 34(7):361-72. PubMed ID: 23769624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug transporters in drug efficacy and toxicity.
    DeGorter MK; Xia CQ; Yang JJ; Kim RB
    Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation.
    Apáti Á; Szebényi K; Erdei Z; Várady G; Orbán TI; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2016; 12(1):77-92. PubMed ID: 26592535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.
    Gerloff T
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):69-77. PubMed ID: 14598019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
    Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
    Langer O
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S143-56. PubMed ID: 27385172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
    Yang X; Han L
    Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport mechanisms at the pulmonary mucosa: implications for drug delivery.
    Nickel S; Clerkin CG; Selo MA; Ehrhardt C
    Expert Opin Drug Deliv; 2016; 13(5):667-90. PubMed ID: 26909544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.